Waterloo Exchange
Fifth Floor Waterloo Road
Dublin D04 E5W7
Ireland
353 1 634 7800
https://www.jazzpharma.com
Setor(es): Healthcare
Indústria: Biotechnology
Funcionários Integrais: 2.800
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Bruce C. Cozadd | Co-Founder, Chairman & CEO | 2,45M | 13,66M | 1964 |
Ms. Reneé D. Galá | President & COO | 1,13M | N/A | 1972 |
Dr. Robert Iannone M.D. | Executive VP and Global Head of Research & Development | 1,08M | N/A | 1967 |
Mr. Philip L. Johnson | Executive VP & CFO | N/A | N/A | N/A |
Ms. Patricia Carr | Senior VP & Chief Accounting Officer | N/A | N/A | 1972 |
Ms. Andrea N. Flynn Ph.D. | VP & Head of Investor Relations | N/A | N/A | N/A |
Ms. Neena M. Patil J.D. | Executive VP & Chief Legal Officer | 331,61k | N/A | 1976 |
Ms. Heidi Manna | Executive VP & Chief People Officer | N/A | N/A | 1972 |
Dr. Jed Black M.D. | Senior Vice President of Sleep & CNS Medicine | N/A | N/A | N/A |
Ms. Samantha Pearce | Senior Vice President of Europe & International | N/A | N/A | 1966 |
O QualityScore de governança da ISS da Jazz Pharmaceuticals plc a partir de 1 de abril de 2024 é 3. As principais pontuações para Auditoria são: 6; Conselho: 3; Direitos de Acionistas: 3; Compensação: 4.